HEALTHSTORY 567· JUNE 26, 2026

Delphia Therapeutics Names David Kerstein as Chief Medical Officer

Delphia Therapeutics has appointed David Kerstein as its chief medical officer. Kerstein arrives with direct experience in the role, having previously served as CMO at both IDRx and Theseus Pharmaceuticals — a track record that matters in…

NDNewsDialy Desk1 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 566Democratic Senators Push FCC to Freeze Paramount-Warner Bros Discovery Merger on Foreign Ownership Grounds NEXT STORY 568 →Four Ethereum Early Adopters Cash Out 37,602 ETH, Walking Away With $27M After $150M Peak Evaporated

Keep reading

More from the desk.

23HEALTH

Seven months after launch, Aurora Therapeutics scraps its lead gene-editing program and cuts staff

Personalized CRISPR therapies, gene-editing treatments built around one patient's specific mutation rather than a disease shared by millions, just lost one of their early backers. Aurora Therapeutics has scrapped its lead program and laid…

health2 MIN

38HEALTH

California Supreme Court rules Gilead Sciences has no legal duty to fast-track a safer HIV drug

Pharmaceutical companies do not owe patients a legal duty to speed up development of a safer drug simply because a less safe version is already on the market. That concept, called a "duty to innovate," was at the center of a case brought…

health2 MIN

49HEALTH

Trump administration shifts 340B drug program from upfront discounts to rebates, drawing hospital backlash

A federal law requires pharmaceutical manufacturers to sell discounted medicines to specific hospitals and clinics. That discount mechanism, the foundation of the 340B Drug Pricing Program, is now being reshaped. The Trump administration…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk